Gardasil hpv vaccine lawsuit claims allege that Merck’s HPV vaccine caused serious autoimmune and neurological injuries. Thousands of individuals received Gardasil as teenagers. Many now report debilitating conditions that appeared shortly after vaccination. These federal cases are consolidated under MDL-3036 in the Western District of North Carolina. The litigation represents one of the most closely watched vaccine injury disputes in recent years. However, the path forward has proven complex due to federal preemption rulings and strict filing deadlines.
Case Timeline
Last checked: May 22, 2026
What Is the Gardasil Hpv Vaccine Lawsuit About?
| MDL Detail | Current Data |
|---|---|
| MDL Number | MDL-3036 |
| Pending Cases | 129 |
| Presiding Judge | TBD |
| Federal District | TBD |
| Data Source | U.S. Judicial Panel on Multidistrict Litigation |
| Last Updated | June 01, 2026 |
The gardasil hpv vaccine lawsuit centers on claims that Merck & Co. failed to adequately warn patients about serious side effects. Gardasil was first approved by the FDA in 2006 to prevent certain HPV-related cancers. Merck later introduced Gardasil 9, a nine-valent version, in 2014. Plaintiffs allege the vaccine’s aluminum-based adjuvant triggers autoimmune responses. These responses allegedly cause lasting harm in a subset of recipients.
The most commonly alleged injuries include Postural Orthostatic Tachycardia Syndrome (POTS), a condition causing abnormal heart rate upon standing. Plaintiffs also report Premature Ovarian Insufficiency (POI), Complex Regional Pain Syndrome (CRPS), and Guillain-Barré Syndrome. In most cases, symptoms appeared within weeks or months of receiving the vaccine. Many plaintiffs were teenage girls at the time of vaccination. Their injuries allegedly disrupted education, careers, and daily life.
Merck is the sole defendant in the litigation. The company maintains that Gardasil’s FDA-approved labeling is adequate. Merck also argues that no scientifically established causal link exists between the vaccine and these conditions. As a result, the core legal battle involves whether current science supports the plaintiffs’ injury claims.
MDL Case Status and Key Facts
| Detail | Information |
|---|---|
| MDL Number | 3036 |
| Full Title | In re: Gardasil Products Liability Litigation |
| Presiding Judge | Judge Kenneth D. Bell |
| Federal District | Western District of North Carolina |
| Approximate Pending Cases | ~160 |
| Defendant | Merck & Co., Inc. |
| Primary Alleged Injuries | POTS, POI, CRPS, Guillain-Barré Syndrome |
| Bellwether Trials (Federal) | None completed; cases dismissed on preemption grounds |
The gardasil hpv vaccine lawsuit suffered a major setback in March 2025. Judge Bell granted Merck summary judgment on implied federal preemption. The ruling found that Merck could not unilaterally change its FDA-approved label. Therefore, state-law failure-to-warn claims directly conflicted with federal labeling requirements. This decision effectively dismissed hundreds of federal cases.
Plaintiffs appealed to the U.S. Court of Appeals for the Fourth Circuit in July 2025. That appeal challenges both the preemption ruling and an earlier decision limiting plaintiffs’ expert witnesses. For example, in February 2025, Judge Bell excluded key portions of a plaintiff regulatory expert’s testimony under Rule 702. The court found the expert lacked qualifications to opine on medical causation for POTS and POI. These appellate proceedings remain a critical turning point for the litigation.
Who Qualifies for the Gardasil Hpv Vaccine Lawsuit?
Individuals who received Gardasil or Gardasil 9 and later developed serious autoimmune or neurological conditions may qualify. Typically, plaintiffs received the vaccine between 2006 and the present. Qualifying injuries generally include POTS, premature ovarian insufficiency, CRPS, Guillain-Barré Syndrome, chronic fatigue, and other dysautonomia disorders. Symptoms must have appeared after vaccination, and medical records should document the diagnosis.
However, a critical eligibility requirement involves the Vaccine Injury Compensation Program (VICP). Under the National Childhood Vaccine Injury Act, plaintiffs must first file a VICP petition before pursuing a civil lawsuit. The VICP filing deadline is three years from the onset of first symptoms. This deadline is strictly enforced. In September 2025, the Fourth Circuit affirmed dismissal of three bellwether cases that missed this deadline.
This timing requirement has barred many potential claimants. Individuals who received Gardasil years ago and only recently connected their symptoms to the vaccine may find themselves time-barred. Anyone considering a gardasil hpv vaccine lawsuit claim should consult a licensed attorney immediately to evaluate whether filing deadlines have passed.
How to File a Gardasil Hpv Vaccine Lawsuit Claim
Filing a gardasil hpv vaccine lawsuit involves a specific legal process. First, a claimant must file a petition with the VICP through the U.S. Court of Federal Claims. This step is mandatory before any civil lawsuit can proceed. An experienced vaccine injury attorney can prepare and submit the VICP petition. The petition must include medical records documenting the vaccination and subsequent injury.
If the VICP denies the claim or the petitioner elects to leave Vaccine Court, a civil products liability lawsuit may follow. At that point, individual state statutes of limitations apply. These deadlines typically range from two to three years. In the federal MDL track, cases are consolidated before Judge Bell for pretrial proceedings. Plaintiffs typically complete a Plaintiff Fact Sheet detailing their vaccination history and medical conditions.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Given the complexity of vaccine litigation, finding qualified legal counsel is essential. A gardasil hpv vaccine lawsuit attorney should understand both the VICP process and the MDL procedures. Many firms handling these cases offer free consultations. Time is a critical factor because missed deadlines cannot be cured. As a result, anyone who suspects a vaccine-related injury should seek legal advice promptly.
Settlement Updates and What to Expect
As of May 2026, no global settlement has been reached in the gardasil hpv vaccine lawsuit MDL. Merck has not publicly indicated willingness to negotiate a resolution. Industry observers note that meaningful settlement discussions typically follow an adverse bellwether verdict. No federal bellwether trial has been completed in MDL-3036 due to the preemption dismissals.
However, the California state court track offers a separate path. The first-ever Gardasil trial — Robi v. Merck — began in January 2025 in Los Angeles Superior Court. The plaintiff alleged she was confined to a wheelchair after receiving Gardasil as a teenager. The trial was halted in February 2025 after approximately 17 days of testimony. A retrial was scheduled for September 2025. California state cases are not subject to the federal preemption ruling.
The timeline for any gardasil hpv vaccine lawsuit resolution remains uncertain. Several factors will influence outcomes. These include the Fourth Circuit’s ruling on the preemption appeal and any future trial verdicts. The strength of expert causation testimony will also matter significantly. Plaintiffs who believe they have a valid claim should not wait for a settlement announcement. Statutes of limitations continue to run regardless of MDL proceedings.
State-by-State Considerations
State tort reform laws can significantly affect a gardasil hpv vaccine lawsuit claim. Each state sets its own statute of limitations for personal injury cases. For example, some states allow only two years from discovery of injury. Others provide three years or more. Damage caps and evidentiary standards also vary. States like California, Texas, North Carolina, Pennsylvania, and New York have notable plaintiff counts in this litigation.
Additionally, state court filings may proceed independently of the federal MDL. The California Robi v. Merck case demonstrates this parallel path. Plaintiffs in states with favorable tort laws may find strategic advantages in state court. A licensed attorney familiar with your state’s laws can evaluate the best forum. You can learn more about how state tort reform laws may affect your potential claim.
Frequently Asked Questions
Is the gardasil hpv vaccine lawsuit still active in 2026?
Yes, though the federal MDL has been significantly impacted by the March 2025 preemption ruling. Plaintiffs have appealed to the Fourth Circuit. California state court cases continue separately. New claims may still be filed if VICP deadlines have not expired.
What injuries qualify for a gardasil hpv vaccine lawsuit claim?
The most common alleged injuries include POTS, Premature Ovarian Insufficiency, Complex Regional Pain Syndrome, and Guillain-Barré Syndrome. Other autoimmune and neurological conditions may also qualify. Medical documentation linking the injury to vaccination is typically required.
Do I need to file with Vaccine Court before suing Merck?
Yes. Under the National Childhood Vaccine Injury Act, you must first file a VICP petition within three years of your first symptoms. This requirement is strictly enforced. If you miss this deadline, you might be permanently barred from civil litigation. Consult a licensed attorney to determine your eligibility.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- U.S. Judicial Panel on Multidistrict Litigation (JPML)
- U.S. Department of Justice
- FDA Safety Alerts & Recalls
- Centers for Disease Control and Prevention
- U.S. Environmental Protection Agency
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Illinois Tort Reform Guide
- New Jersey Tort Reform Guide
- California Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.